Lewes, DE -- (SBWIRE) -- 10/09/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: CHINA CONSTRUCTION B (OTCMKTS:CICHY), American Eagle Energy Corp (OTCBB:AMZG), Evcarco Inc (OTCMKTS:EVCA), Advaxis, Inc. (OTCBB:ADXS).
CHINA CONSTRUCTION B (OTCMKTS:CICHY) opened its last trade at the price of $15.52. Its closing price was $15.49 after losing -0.51% for the day. The company traded with the total volume of 62.979 shares, while its average trading volume remained 82.227 shares. The beta of this stock stands at 0.97. China Construction Bank Corporation, together with its subsidiaries, provides corporate and personal banking, and treasury services.
Will CICHY Get Buyers Even After The Recent Rally? Find Out Here
American Eagle Energy Corp (OTCBB:AMZG) percentage change surged 1.04% to close at $1.94 with the total traded volume of 72.483 shares while its average volume of 214.983 shares. The 52 week range of the stock remained $0.59 - $2.49, while its day lowest price was $1.89. The share price hit the day highest price of $1.95. American Eagle Energy Corporation engages in the acquisition, exploration, development, and production of oil and gas properties in Canada and the United States.
Will AMZG Continue To Move Higher? Find Out Here
Evcarco Inc (OTCMKTS:EVCA) traded on volume of 187.19 million shares in the last session against average volume of 30.48 million shares. The company closed at $0.0004 and showed no change. In the last three months the stock was up 100%.EVCARCO, Inc. operates as a new car franchised Dealership Company. The company engages in the sale of environmentally conscious automobiles, including new electric and pre-owned vehicles.
Can Investors Bet on EVCA after this News update? Find Out Here
Advaxis, Inc. (OTCBB:ADXS) started its last trading session with the price of $4.52 and closed at $4.95 by scoring 9.27%. The stock traded with total volume of 47.067 shares, while the average trading volume remained 60.125 shares. The beta value of this stock stands at 1.73. Day range for the stock was $4.52 and $4.95. Advaxis, Inc., a clinical development stage biotechnology company, engages in the development of immunotherapies for cancer and infectious diseases.
Will ADXS Continue To Move Higher? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)